Remifentanil Hydrochloride Injection — FDA Drug Shortage
The FDA lists a drug shortage record for Remifentanil Hydrochloride Injection (injection) from Mylan Institutional, A Viatris Company with status Current. The shortage was first posted on Jun 28, 2022.
Shortage details
- Status
- Current
- Company
- Mylan Institutional, A Viatris Company
- Package NDC
- 72078-035-02
- Dosage Form
- Injection
- Presentation
- Ultiva, Injection, 2 mg (NDC 72078-035-02)
- Initial Posting
- Jun 28, 2022